Frontiers in Oncology | Molecular and Cellular Oncology

Correction

Published on 04 Sep 2025

Correction: Cucurbitacin B inhibits HIF-1α and attenuates non-small cell lung cancer via ZFP91

in Molecular and Cellular Oncology

Lei Song
Jing Han
Run Wang
Shen Cao
Yi Tai
Xinyu Wang
Yanjin Zheng
Shufeng Jin
Yue Xing
Hong Xiang Zuo

Frontiers in Oncology

doi 10.3389/fonc.2025.1684497

1,293 views

Review

Published on 03 Sep 2025

The pivotal role of TGF-β/Smad pathway in fibrosis pathogenesis and treatment

in Molecular and Cellular Oncology

Feilong Chen
Lei Lyu
Chengyuan Xing
Yu Chen
Shaofan Hu
Meng Wang
Zhengdong Ai

Frontiers in Oncology

doi 10.3389/fonc.2025.1649179

6,021 views
2 citations

Original Research

Published on 02 Sep 2025

Construction of a glycosylation-related prognostic signature for predicting prognosis, tumor microenvironment, and immune response in soft tissue sarcoma

in Molecular and Cellular Oncology

Ningning Yuan
Jinfeng Zhang
Junhui Yuan
Zhou Xie
Yuanjun Gao
Muqaddas Raza
Yutong Gao
Guowei Zuo

Frontiers in Oncology

doi 10.3389/fonc.2025.1636830

1,682 views

Correction

Published on 02 Sep 2025

Correction: Curcumin inhibits colorectal cancer progression by targeting PTBP1 and CDK2-mediated pathways

in Molecular and Cellular Oncology

Hao Zheng
Shenglong Li
Ye Wang
Shuang Su
Yiheng Wang
Fujing Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1659429

862 views
1 citation

Original Research

Published on 27 Aug 2025

ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity

in Molecular and Cellular Oncology

Sofia Morazzo
Soraia Fernandes
Marina Fortea
Helena Skálová
Daniel Pereira-Sousa
Marco Cassani
Kamila Vrzalová
Filip Kafka
Jan Vrbský
Mathilde Soulez

Frontiers in Oncology

doi 10.3389/fonc.2025.1563969

1,966 views

Original Research

Published on 27 Aug 2025

REST corepressor 2 contributes to the cell proliferation of endometrial cancer

in Molecular and Cellular Oncology

Qingjuan Zhu
Xin Yang
Yuchun Lv

Frontiers in Oncology

doi 10.3389/fonc.2025.1539263

1,118 views

Original Research

Accepted on 26 Aug 2025

The association between serum KLF-5 levels and clinicopathologic characteristics of patients with non-small cell lung cancer (NSCLC) and its predictive value for prognosis

in Molecular and Cellular Oncology

Wenhui Xu

Frontiers in Oncology

300 views

Review

Published on 25 Aug 2025

High risk factors, molecular features and clinical management for radioactive iodine-refractory differentiated thyroid carcinoma

in Molecular and Cellular Oncology

Tengyun Ma
Yiting Xie
Xinyi Long
Feng Ye

Frontiers in Oncology

doi 10.3389/fonc.2025.1644562

2,120 views
1 citation

Original Research

Published on 22 Aug 2025

EPHA2 promotes triple-negative breast cancer progression by suppressing pyroptosis via the AKT/PI3K/mTOR pathway

in Molecular and Cellular Oncology

Xiaoying Huang
Li Na
Qingkai Han
Qilun Liu
Ligang Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1620122

2,255 views

Brief Research Report

Published on 22 Aug 2025

Raw lacquer-associated familial chronic myelomonocytic leukemia with multi-hit TET2 mutations

in Molecular and Cellular Oncology

Yang Zhang
Yujiao Luo
Hongling Peng
Yafei Yin
Guangsen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1605369

1,132 views

Mini Review

Published on 22 Aug 2025

Ferroptosis in the tumor microenvironment: mechanisms, advances, and therapeutic perspectives

in Molecular and Cellular Oncology

Weijuan Gao
Jiani Tan
Chengtao Yu

Frontiers in Oncology

doi 10.3389/fonc.2025.1650219

2,681 views
1 citation

Review

Published on 20 Aug 2025

Roles of long non-coding RNA HULC in human digestive system cancers

in Molecular and Cellular Oncology

Liqing Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1642425

2,475 views

Correction

Published on 19 Aug 2025

Correction: Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis

in Molecular and Cellular Oncology

Izabela Krauze
Beata Greb-Markiewicz
Anna Kłopot
Kamila Maciejewska
Michał Bryk
Małgorzata Krzystek-Korpacka

Frontiers in Oncology

doi 10.3389/fonc.2025.1663602

940 views

Review

Published on 15 Aug 2025

Cellular senescence in colorectal cancer: its occurrence, effect and therapy

in Molecular and Cellular Oncology

Yabing Liang
Miao Wang
Xianjue Wang
Zhiqing Yang
Shucheng Wang
Fengyi Li
Liya Su
Ling Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1580951

3,357 views

Case Report

Published on 14 Aug 2025

Mucinous adenocarcinoma of the prostate with extremely low prostate-specific antigen levels, recurrent disease: a case report

in Molecular and Cellular Oncology

Xu Yu
Jie Yuan
Zhiming Wang
Niannian Wang
Xiangfei He
Jie Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1645306

966 views

Mini Review

Published on 13 Aug 2025

Molecular mechanism of aerobic exercise in miRNAs and the anti-tumoral effects

in Molecular and Cellular Oncology

Merve Çulha
Fabio S. Lira
Jose C. Rosa-Neto

Frontiers in Oncology

doi 10.3389/fonc.2025.1595982

1,271 views

Review

Published on 13 Aug 2025

Application of artificial intelligence-based stemness index in cancer

in Molecular and Cellular Oncology

Liyuan Liu
Qin Pei
Javeria Qadir
Yiyu Chen
Jingyuan Li
Yanan Luo
Jiawen Xian
Rongrong Du
Ting Ye

Frontiers in Oncology

doi 10.3389/fonc.2025.1608712

1,568 views
1 citation

Original Research

Published on 11 Aug 2025

Cucurbitacin B inhibits HIF-1α and attenuates non-small cell lung cancer via ZFP91

in Molecular and Cellular Oncology

Lei Song
Jing Han
Run Wang
Shen Cao
Yi Tai
Xinyu Wang
Yanjin Zheng
Shufeng Jin
Yue Xing
Hong Xiang Zuo

Frontiers in Oncology

doi 10.3389/fonc.2025.1607264

2,032 views

Systematic Review

Published on 11 Aug 2025

A systematic review and exploration of clinical application of liver depression syndrome in breast cancer

in Molecular and Cellular Oncology

Peng Wu
Siying Mao
Qian Zuo
Qianqian Guo
Qianjun Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1614903

2,350 views

Original Research

Published on 05 Aug 2025

Chorordin-like 1 inhibits pancreatic cancer cell migration and invasion: involvement of the BMP4/SMAD pathway

in Molecular and Cellular Oncology

Wei Li
Yalan Zhong
Yuqiao Song
Hongmei Wang
Zheng Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1633464

1,809 views

Review

Published on 31 Jul 2025

Advances in research on RNA methylation and cancer radiotherapy resistance

in Molecular and Cellular Oncology

Hui Liu
Hui Luo
Ming Jin
Zhen Zheng
Yang Xi
Kaitai Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1596541

2,383 views

Review

Published on 29 Jul 2025

YBX1: an RNA/DNA-binding protein that affects disease progression

in Molecular and Cellular Oncology

Xifeng Zheng
Feng Zeng
Yan Lei
Yanling Li
Jun Deng
Gengqiu Luo
Qian He
Yanhong Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1635209

3,101 views
1 citation

Original Research

Published on 28 Jul 2025

The construction and evaluation of a prognostic risk score model for HCC based on MPT-related lncRNAs

in Molecular and Cellular Oncology

Zerun Lin
Jianda Yu
Zhijian Chen
Jingyi Chen
Xiaobin Chi
Honghuan Lin
Yongbiao Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1590094

1,773 views

Review

Published on 25 Jul 2025

The effect of ubiquitination and deubiquitination to imatinib resistance in gastrointestinal stromal tumors

in Molecular and Cellular Oncology

Huade Huo
Haolin Li
Xinlin Yang
Shu Wang
Yan Zhao
Jianjun Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1581920

2,149 views

3,127 articles

articles

Correction: Cucurbitacin B inhibits HIF-1α and attenuates non-small cell lung cancer via ZFP91

The pivotal role of TGF-β/Smad pathway in fibrosis pathogenesis and treatment

Construction of a glycosylation-related prognostic signature for predicting prognosis, tumor microenvironment, and immune response in soft tissue sarcoma

Correction: Curcumin inhibits colorectal cancer progression by targeting PTBP1 and CDK2-mediated pathways

ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity

REST corepressor 2 contributes to the cell proliferation of endometrial cancer

The association between serum KLF-5 levels and clinicopathologic characteristics of patients with non-small cell lung cancer (NSCLC) and its predictive value for prognosis

High risk factors, molecular features and clinical management for radioactive iodine-refractory differentiated thyroid carcinoma

EPHA2 promotes triple-negative breast cancer progression by suppressing pyroptosis via the AKT/PI3K/mTOR pathway

Raw lacquer-associated familial chronic myelomonocytic leukemia with multi-hit TET2 mutations

Ferroptosis in the tumor microenvironment: mechanisms, advances, and therapeutic perspectives

Roles of long non-coding RNA HULC in human digestive system cancers

Correction: Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis

Cellular senescence in colorectal cancer: its occurrence, effect and therapy

Mucinous adenocarcinoma of the prostate with extremely low prostate-specific antigen levels, recurrent disease: a case report

Molecular mechanism of aerobic exercise in miRNAs and the anti-tumoral effects

Application of artificial intelligence-based stemness index in cancer

Cucurbitacin B inhibits HIF-1α and attenuates non-small cell lung cancer via ZFP91

A systematic review and exploration of clinical application of liver depression syndrome in breast cancer

Chorordin-like 1 inhibits pancreatic cancer cell migration and invasion: involvement of the BMP4/SMAD pathway

Advances in research on RNA methylation and cancer radiotherapy resistance

YBX1: an RNA/DNA-binding protein that affects disease progression

The construction and evaluation of a prognostic risk score model for HCC based on MPT-related lncRNAs

The effect of ubiquitination and deubiquitination to imatinib resistance in gastrointestinal stromal tumors